Drug News
-
Biogen Faces Setback as Europe Revokes Marketing Authorization for Tecfidera Generics
In a significant development, Biogen Inc. announced on Tuesday that the European Commission has revoked the marketing authorization for generic…
Read More » -
Judge Dismisses Tylenol-Autism Link Lawsuits, Citing Lack of Scientific Support
In a significant legal development, a judge has ruled against expert witnesses who claimed that Tylenol, a painkiller produced by…
Read More » -
G-Dragon Triumphs: K-Pop Icon Cleared of Drug Allegations in Stunning Police Decision
In a recent turn of events, South Korean police have officially cleared K-Pop sensation G-Dragon, also known as Kwon Ji-yong,…
Read More » -
AvertD Test: FDA Unveils Breakthrough in Predicting Opioid Addiction, Sparking Pain Management Revolution
In a groundbreaking move, the U.S. Food and Drug Administration (FDA) announced on Tuesday its approval of the first-ever test…
Read More » -
GSK’s Cancer Drug Combination Achieves Primary Goal in Late-Stage Trial for Endometrial Cancer
GlaxoSmithKline (GSK) announced on Monday that the combination of its cancer drugs Zejula and Jemperli, utilized as a maintenance therapy…
Read More » -
Weight-Loss Drug Excitement Overshadows Market Realities in 2023
In 2023, the enthusiasm surrounding weight-loss drugs, particularly Novo Nordisk’s Wegovy (also known as Ozempic) and Eli Lilly’s Zepbound, has…
Read More » -
IndiaMART Removes Unauthorized Listings of Novo Nordisk’s Wegovy Following Talks
IndiaMART, a prominent Indian online marketplace, has taken steps to remove unauthorized listings of Novo Nordisk’s blockbuster weight-loss drug Wegovy,…
Read More » -
Jordan Foils Armed Plot by Infiltrators from Syria Linked to Pro-Iranian Militias
The Jordanian army successfully thwarted a major cross-border operation on Monday, revealing a plot orchestrated by dozens of infiltrators from…
Read More » -
RNAimmune, Partner of Innoforce, Receives FDA IND Clearance for Groundbreaking RSV mRNA Vaccine
RNAimmune, Inc., a strategic partner of Innoforce Pharmaceuticals, has achieved a major milestone with the U.S. Food and Drug Administration…
Read More » -
FDA Clears NRX-101: Investigational Drug for Complicated UTIs by NRx
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, has announced a significant milestone with the FDA’s clearance of its…
Read More »